ABIONYX Pharma SA (EPA:ABNX)
France · Delayed Price · Currency is EUR 1.840
+0.032 (1.77%)
Sep 11, 2026, 5:39 PM CET
ABIONYX Pharma Market Cap
ABIONYX Pharma has a market cap or net worth of €77.9 million as of September 11, 2026. Its market cap has decreased by -37.86% in one year.
Market Cap
77.90M
Enterprise Value
78.19M
Revenue
4.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.84
ChartMarket Cap Chart
Since March 30, 2015, ABIONYX Pharma's market cap has decreased from 214.16M to 77.90M, a decrease of -63.62%. That is a compound annual growth rate of -8.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 77.90M | -41.66% |
| Dec 31, 2025 | 133.53M | 223.58% |
| Dec 31, 2024 | 41.27M | -0.54% |
| Dec 29, 2023 | 41.49M | -14.37% |
| Dec 30, 2022 | 48.45M | -28.38% |
| Dec 31, 2021 | 67.65M | 178.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Transgene | 241.56M |
| Cellectis | 199.05M |
| Innate Pharma | 149.71M |
| Sensorion | 119.67M |
| Adocia | 74.35M |
| OSE Immunotherapeutics | 64.63M |
| MaaT Pharma | 52.57M |
| THX Pharma Société Anonyme | 46.63M |